Cargando…

Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation

Detalles Bibliográficos
Autores principales:	Yang, Jie, Yang, Jun-Jun, Zhao, Jun, Ren, Tong, Feng, Feng-Zhi, Wan, Xi-Run, Xiang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Clinical Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421185/ https://www.ncbi.nlm.nih.gov/pubmed/28469110 http://dx.doi.org/10.4103/0366-6999.204922

Ejemplares similares

Pulmonary deportation of hydatidiform mole: a 12-year, single tertiary center experience in China
por: Dai, Yu-Xin, et al.
Publicado: (2020)

Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study
por: Wang, Xiaoyu, et al.
Publicado: (2023)

Subepithelial hematoma of the esophagus: an unusual cause of chest pain and dysphagia
por: Shi, Wen, et al.
Publicado: (2023)

Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, randomized trial
por: Jiang, Fang, et al.
Publicado: (2023)

Unusual Cases of Ovarian Cyst
por: Wanless, N. J.
Publicado: (1907)

Management and Predictors of Treatment Failure in Patients with Chemo-Resistant/Relapsed Gestational Trophoblastic Neoplasia with Lung Metastasis
por: Kong, Yujia, et al.
Publicado: (2022)

Clinical analysis of 13 males with primary choriocarcinoma and review of the literature
por: Jiang, Fang, et al.
Publicado: (2014)

Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review
por: Sam Saji, Alen, et al.
Publicado: (2023)

Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma
por: Liu, Weiping, et al.
Publicado: (2023)

Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia
por: Xue, Wei, et al.
Publicado: (2023)

An unusual cause of neck cellulitis
por: Rakovich, George, et al.
Publicado: (2023)

An unexpected N-terminal loop in PD-1 dominates binding by nivolumab
por: Tan, Shuguang, et al.
Publicado: (2017)

Relapsed Myasthenia Gravis after Nivolumab Treatment
por: Mitsune, Ayumi, et al.
Publicado: (2018)

Relapsing fever in a traveller returning from Senegal
por: Eckbo, Eric J., et al.
Publicado: (2021)

Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance
por: Lorusso, Domenica, et al.
Publicado: (2020)

An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
por: Talreja, Vikas T., et al.
Publicado: (2019)

Primary ovarian insufficiency
por: Brent, Shannon, et al.
Publicado: (2023)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
por: Nose, Taku, et al.
Publicado: (2022)

The Role of Metformin in Ovarian Cancer: Does Metformin Increase Survival in Ovarian Neoplasm?
por: Ahmed, Maimuna F, et al.
Publicado: (2021)

Initial experience of anti-PD1 therapy with nivolumab in advanced hepatocellular carcinoma
por: Feng, Duan, et al.
Publicado: (2017)

Nivolumab (PD-1 Inhibitor) Induced Exacerbation of Psoriasis
por: George, Anju, et al.
Publicado: (2020)

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299
por: Dudek, Arkadiusz Z., et al.
Publicado: (2023)

Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report
por: Yang, Wei, et al.
Publicado: (2021)

P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment
por: Fedorova, Liudmila, et al.
Publicado: (2022)

Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
por: Paoluzzi, L., et al.
Publicado: (2016)

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors
por: Chang, Hyeyoon, et al.
Publicado: (2017)

Massive Pulmonary Embolism in Recovery Period of General Anesthesia: Rapid Diagnosis and Successful Rescue by the Guidance of Transthoracic Echocardiography
por: Xu, Mao, et al.
Publicado: (2017)

Impact of preoperative anemia on relapse and survival in breast cancer patients
por: Zhang, YingJun, et al.
Publicado: (2014)

Combining PD-1 Inhibitor Nivolumab with Radiotherapy Successfully Treated a Patient with Refractory Primary Mediastinal Large B-Cell Lymphoma: A Case Report and Literature Review
por: Yan, Zheng, et al.
Publicado: (2020)

Virilization caused by ovarian nodular hyperthecosis in a postmenopausal woman
por: Tulandi, Togas, et al.
Publicado: (2022)

Relapsing lupus enteritis in systemic lupus erythematosus
por: Kim, Yaerim, et al.
Publicado: (2016)

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report
por: Narumi, Yoshitsugu, et al.
Publicado: (2018)

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
por: Lepik, Kirill V., et al.
Publicado: (2020)

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
por: Fedorova, Liudmila V., et al.
Publicado: (2021)

Nivolumab-DTPA-Based PD-1 Imaging Reveals Structural and Pathological Changes in Colorectal Carcinoma
por: Li, Danni, et al.
Publicado: (2022)

Nivolumab for malignant transformation of ovarian mature cystic teratoma
por: Yoshimura, Kayoko, et al.
Publicado: (2022)

Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
por: Friedman, Claire F, et al.
Publicado: (2022)

Lung Cancer with Diffuse Ground-glass Shadow in Two Lungs and Respiratory Failure
por: Feng, Zhe-Min, et al.
Publicado: (2016)

Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series
por: Matsuo, Koji, et al.
Publicado: (2018)

Unusual Cause of Chest Pain on Radiograph
por: Gallitelli, Mauro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e9j2rvegk20ktsl1rm86fefap8